Patent ID: 11951311
Assignee: AVENT, INC.
Field: Medical technology (Instruments)
Classification: CPC A | IPC A

Claim 7:
8. The system of claim 1, wherein the nervous system structure comprises the sphenopalatine ganglion (SPG),
wherein the controller is adjustable to vary a parameter of the transmucosal electrical stimulation delivered to the treatment site to selectively modulate the neural and non-neural tissue of the SPG and selectively modulate nerve signal transmission through nerve fibers of the SPG responsible for the transmission of pain,
wherein the parameter is selected from the group consisting of a waveform shape, a waveform frequency, a waveform amplitude, an electrical field strength generated at the electrode, a waveform DC offset, and a waveform duty cycle, a tissue temperature, an electrode temperature, a cooling mechanism parameter, and a treatment duration.